Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S 1090

Known as: S-1090 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Cefmatilen hydrochloride hydrate (S-1090) was administered at 500 and 1000 mg potency/kg once orally to beagle dogs. No deaths… Expand
Is this relevant?
2001
2001
Cefmatilen hydrochloride hydrate (S-1090), a new non-ester type of orally active cephem antibiotic synthesized in Shionogi… Expand
Is this relevant?
2001
2001
A nephrotoxicity study of Cefmatilen hydrochloride hydrate (S-1090) was conducted in rabbits at single oral doses of 250, 500 and… Expand
Is this relevant?
2001
2001
To evaluate the repeated oral dose toxicity of Cefmatilen hydrochloride hydrate (S-1090) in juvenile dogs, S-1090 was… Expand
Is this relevant?
1999
1999
Direct injection high-performance liquid chromatographic (HPLC) methods with column switching and UV detection were developed for… Expand
Is this relevant?
1998
1998
S-1090 is a new synthetic, nonesterified, oral cephalosporin with a broad spectrum of antibacterial activity. The activities of S… Expand
  • figure 1
  • table 1
Is this relevant?
1997
1997
A new oral cephem antibiotic S-1090 was evaluated for its in vitro antibacterial activity in comparison with cefdinir… Expand
Is this relevant?
1996
1996
S-1090, an oral cephem antibiotic, was given to healthy male volunteers in single (10 to 400 mg) and multiple (200 mg, twice a… Expand
  • figure 1
  • table 1
Is this relevant?
1995
1995
S-1090, a new oral cephalosporin, was active against selected gram-negative bacteria and methicillin-susceptible clinical… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
1995
1995
AbstractPurpose. Elucidating the transport characteristics of S-1090, a new orally active cephalosporin in rat small intestinal… Expand
Is this relevant?